Are Riata concerns a thing of the past and transcatheter aortic valve replacement (TAVR) for almost anyone with severe aortic stenosis the way of the future? Presentations at recent cardiology conferences addressed those questions.

Edwards Lifesciences put enrollment into a program using its FORTIS transcatheter valve replacement therapy on hold, announcing that it wants to investigate reports of valve thrombus.

Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery in low-risk patients with severe aortic stenosis, based on two-year results presented May 19 at EuroPCR in Paris.

A panel of experts recommended that remote monitoring become the standard of care for patients with cardiovascular implantable electronic devices (CIEDs), according to a consensus statement from the Heart Rhythm Society (HRS). The statement was published online in Heart Rhythm on May 13.

St. Jude Medical, Inc., a global medical device company, today announced important new data presented during the Heart Rhythm Society's (HRS) 36th annual Scientific Session supporting improved outcomes and cost-effectiveness of the CardioMEMS™ HF System for the management of Class III heart failure patients.

The Heart Rhythm Society (HRS) has released a first-of-its-kind expert consensus statement on three specific cardiovascular disorders that also involve the autonomic nervous system. The 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope was written by an international group of experts and presented today at Heart Rhythm 2015, the Heart Rhythm Society’s 36th Annual Scientific Sessions.

Accreditation for Cardiovascular Excellence (ACE) has just released the first-ever electrophysiology (EP) and Implantable Cardioverter Defibrillator (ICD) standards for accreditation. Driven by the latest available clinical evidence, the EP and ICD standards are a comprehensive review of interventional procedures in patients and adults with heart rhythm disorders.

Boston Scientific today announced that key data from 42 abstracts will be featured at the 36th Annual Scientific Sessions of the Heart Rhythm Society (HRS) in Boston on May 13-16.